Strumento inattivo

Azioni Ambit Biosciences Corp

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	11/11/14
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	28/10/14
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14/10/14
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	01/10/14
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	01/10/14

Dirigenti	Titolo	Età	Da
Ken Takeshita CEO	Chief Executive Officer	-	-

Amministratori	Titolo	Età	Da
Kenneth Joseph Keller BRD	Director/Board Member	61	10/11/14
Michael Martino CEO	Chief Executive Officer	68	16/11/11
Glenn Gormley BRD	Director/Board Member	-	10/11/14

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,66%	86,13 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 Mrd
BIOGEN INC.	-19,27%	30,42 Mrd
UCB	+57,86%	25,23 Mrd
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,36 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 Mrd
INCYTE CORPORATION	-17,69%	11,6 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 Mrd